Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study.
Claudio AndaloroMaria SantagatiStefania StefaniIgnazio La MantiaPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2019)
We identified potential probiotics, possessing desirable features against GABHS pharyngotonsillitis. Our findings represent the first evidence which throws the light on using these probiotics that can reduce antibiotics use which did not have efficient results regarding recurrence.
Keyphrases
- double blind
- biofilm formation
- placebo controlled
- candida albicans
- young adults
- pseudomonas aeruginosa
- study protocol
- staphylococcus aureus
- clinical trial
- escherichia coli
- free survival
- randomized controlled trial
- squamous cell carcinoma
- human health
- phase ii study
- cystic fibrosis
- radiation therapy
- locally advanced
- rectal cancer